Effectiveness of COVID-19 vaccination in immune-mediated inflammatory diseases
Lancet Rheumatol
.
2022 Jun;4(6):e380-e382.
doi: 10.1016/S2665-9913(22)00109-6.
Epub 2022 Apr 14.
Authors
Jeffrey A Sparks
1
2
,
Namrata Singh
3
,
Zachary S Wallace
2
4
5
Affiliations
1
Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, MA 02115, USA.
2
Department of Medicine, Harvard Medical School, Boston, MA, USA.
3
Division of Rheumatology, University of Washington, Seattle, WA, USA.
4
Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, MA, USA.
5
Clinical Epidemiology Program, Mongan Institute, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
PMID:
35441152
PMCID:
PMC9009834
DOI:
10.1016/S2665-9913(22)00109-6
No abstract available
Grants and funding
P30 AR070253/AR/NIAMS NIH HHS/United States
P30 AR072577/AR/NIAMS NIH HHS/United States
R01 AR077607/AR/NIAMS NIH HHS/United States